← Evidence map

ArticleCell death & disease2022

PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.

Yu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

59 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35121728